Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Stocks - U.S. Futures Surge; Gilead Shines, P&G Scrubs up Well

Published 04/17/2020, 06:59 AM
Updated 04/17/2020, 07:01 AM
© Reuters.

By Peter Nurse

Investing.com - U.S. stocks are set to open strongly higher Friday, as investors look forward to states reopening their economies and grasp at hopes for a cure to the coronavirus.

At 7:15 AM ET (1115 GMT), S&P 500 futures traded 85 points, or 3.1%, higher, Nasdaq futures up 203 points, or 2.3%. The Dow futures contract rose 770 points, or 3.3%.

President Donald Trump laid out new guidelines late Thursday for states to emerge from a coronavirus shutdown in a staggered, three-stage approach.

The recommendations call on states to show a "downward trajectory" of Covid-19 cases or positive tests for the disease over 14 days before gradually loosening restrictions on businesses that have been shuttered to blunt the spread of the virus.

Adding to the positive tone was a media report detailing encouraging partial data from trials of Gilead (NASDAQ:GILD) Sciences’ experimental drug remdesivir in severe Covid-19 patients. Gilead played down the report, saying the trials were incomplete, but its shares have soared 13% in premarket trading.

This news has overshadowed continued weak domestic economic data as well as a slump in China’s gross domestic product, which fell 6.8% in the first quarter, the first drop in almost three decades of records. Monthly data showed industrial production rebounding faster than retail sales as China's lockdown eased.

Procter & Gamble (NYSE:PG)  fiscal third-quarter earnings beat expectations earlier, with organic sales rising 6%, although it has pulled its guidance for the full year. The company boosted its dividend by 6% earlier this week.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Also in the spotlight will be Boeing (NYSE:BA), after it said it would restart some commercial airplane production next week, and Moderna (NASDAQ:MRNA), which said late Thursday that it will receive up to $483 million from the U.S. government to accelerate development of a Covid-19 vaccine.

Elsewhere, Uber (NYSE:UBER) said late Thursday that it was withdrawing guidance and warned it would write down some $2 billion of investments. 

The oil market has seen strong selling in the front month May WTI contract, with extreme levels of oversupply evident in the physical market for both oil and gas, but this has not been replicated in the subsequent contracts.

This market will get more data on the extent of the slowdown in U.S. production when Baker Hughes releases its rig count at 1 PM ET (17:00 GMT).

The oil rig count came in at 504 last week. It was up around 678 at the end of February.

At 7:05 AM ET, U.S. crude futures traded 5.8% lower at $18.70 a barrel, while the international benchmark Brent contract rose 3.1% to $28.68.

Elsewhere, gold futures fell 1.5% to $1,705.20/oz, while EUR/USD traded at $1.0844, up 0.1%.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.